Detection of syndecan-1 has become a useful tool in the diagnosis of some hematological malignancies, since syndecan-1 is expressed in plasmacytoma/plasma cell myeloma, but absent in most types of non-Hodgkin lymphomas [18]. Here, SDC1 is linked to plasma cell myeloma.